Long-stay patients in pediatric intensive care unit: Diagnostic-specific definition and predictors

Angelo Polito1, Christophe Combescure2, Yann Levy-Jamet1

  • 1Pediatric and Neonatal Intensive Care Unit, Department of Pediatrics, University Hospital of Geneva, Geneva, Switzerland.

Plos One
|October 3, 2019
PubMed

Insights

A new definition for long-stay patients (LSPs) in pediatric intensive care units (PICUs) was established, identifying the top 10% of longest stays. Readmission and higher initial acuity predict longer PICU stays, suggesting personalized LSP definitions are needed.

Area of Science:

  • Pediatric Intensive Care
  • Healthcare Management
  • Clinical Informatics

Background:

  • Defining long-stay patients (LSPs) in pediatric intensive care units (PICUs) is crucial for resource allocation and care optimization.
  • Existing definitions may not adequately account for variations in patient populations and diagnoses.
  • A standardized yet adaptable definition is needed to improve patient outcomes and operational efficiency.

Purpose of the Study:

  • To establish a novel definition for LSPs in PICU based on length-of-stay (LOS).
  • To determine if LSP thresholds differ significantly across pediatric age and diagnostic groups.
  • To identify patient characteristics at admission associated with LSP status.

Main Methods:

  • A multicenter retrospective cohort study was conducted across all Swiss PICUs.
  • Long-stay patients (LSPs) were defined as the 10% with the longest PICU length-of-stay (LOS) within specific age and diagnostic groups.
  • Multivariable regression analysis examined associations between admission variables and LSP status.

Main Results:

  • The study included 22,284 pediatric patients.
  • Significantly different LOS thresholds for defining LSPs were observed across diagnostic and age subgroups.
  • Patient readmission to PICU and higher PIM2 and NEMS scores at admission were associated with an increased likelihood of being an LSP.

Conclusions:

  • The definition of LSPs in PICU varies significantly based on specific diagnoses and age categories.
  • Readmission and higher initial acuity are key predictors of longer PICU stays across most diagnostic groups.
  • Personalized LSP definitions, considering patient-specific factors, are recommended for optimizing care and reducing costs.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
688
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
752
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
713
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
461